Rex Bionics
"Reimagining Rehabilitation"
New Zealand-founded medical exoskeleton company producing the REX, a hands-free robotic lower-limb exoskeleton for clinical rehabilitation.
Rex Bionics Limited is a medical robotics company specialising in hands-free robotic exoskeleton technology for rehabilitation. The company was founded on 19 March 2007 and is registered in New Zealand, with its postal address at PO Box 316063, Wairau Valley, Auckland 0760. As of 2026, sources indicate Rex Bionics maintains approximately 13 employees and has offices in multiple countries including the UK (London), though its foundational operations and product development originated in Auckland, New Zealand.
The company's flagship product, REX, is widely recognised as the world's first commercially available hands-free robotic exoskeleton designed for use under clinical supervision. Unlike exoskeletons that require crutches or forearm supports, REX provides a fully self-supporting structure that enables patients with mobility impairments — including those with spinal cord injuries, stroke, multiple sclerosis, and neurological conditions — to stand, walk, and perform weight-bearing exercises without upper-limb assistance.
Technical specifications of the REX exoskeleton: Motion is generated by 10 custom-designed linear actuators powering movement for users up to 100 kg; 27 onboard microprocessors are controlled by approximately 500,000 lines of proprietary software; the structural pelvis and leg cuffs are manufactured from carbon fibre to maximise strength while minimising weight; the full exoskeleton weighs approximately 38 kg; battery system uses lithium-polymer packs rated at 29.6V/16.5Ah, with approximately 60 minutes of continuous use per charge, and two interchangeable batteries are supplied. The system enables fully automated forwards, backwards, sideways, and turning locomotion, plus therapeutic exercises including squats, lunges, sit-to-stand transfers, leg swings, and stretches (collectively branded as REXERCISES).
Rex Bionics offers two commercial configurations: REX Rehab, designed for clinical settings such as rehabilitation hospitals and physiotherapy centres, and REX Personal, intended for private home use by individuals. The device is deployed across rehabilitation centres in Australia, New Zealand, the United Kingdom, Europe, and other international markets. All 50 Australian states and territories have been supplied with at least one REX unit.
Rex Bionics remains an active company as of 2026, continuing to provide rehabilitation exoskeleton technology with a focus on hands-free clinical use.
Primary type & automation activities this supplier delivers:
REX Rehab
Hands-free robotic lower-limb exoskeleton for clinical rehabilitation without crutches.
REX Personal
Home-use version of the REX hands-free robotic exoskeleton for individuals with mobility impairments.
More related news
- 1
- 2
- 3
-
4
CONSTRUCTION ROBOTICS | EXOSKELETONS & HUMAN AUGMENTATION RobotToday · May 04, 2026
-
5
Exoskeletons: The First Scalable Motion Platform for Humanoid Robots RobotToday · Jan 17, 2026
-
6
Hypershell Launches Next Gen Exoskeleton for Everyday Mobility RobotToday · Nov 30, 2025
- 7
- 8
- 9
- 10
-
11
Suzy Teele’s Mission at ARM Institute RobotToday · Oct 13, 2026
-
12
RehabWeek 2027 Lausanne: Rehab Robotics and ICORR RobotToday · Oct 06, 2026
- 13
- 14
- 15
- 16
- 17
- 18
-
19
World-First: China Approves Neuracle’s Invasive BCI for Commercial Use RobotToday · Mar 13, 2026
Contact Rex Bionics
WEBSITE
https://www.rexbionics.comPHONE
+64 9 440 9741HEADQUARTERS
New Zealand
Company Facts
Founded
2007
Primary Role
Manufacturer
Company Size
-
Primary Region
Oceania
Annual Sales
-
Funding Stage
-
Funding Total
-
